Pharmacies - D-A-CH

D-A-CH

In the D-A-CH region, the Pharmacies market is forecasted to achieve a revenue of US$94.87bn in 2024.
It is expected that the market will experience a compound annual growth rate (CAGR 2024-2029) of 3.69%, resulting in a market volume of US$113.70bn by 2029.
When compared globally, United States is projected to generate the highest revenue of US$387.30bn in 2024.
Taking into account the population figures, per person revenues of US$0.94k are estimated for 2024.
In Germany, pharmacies are highly regulated and the majority are owned by pharmacists, ensuring quality and expertise in pharmaceutical care.

Key regions: United States, China, Germany, Japan, Europe

Market

Region

Region comparison

Currency

Analyst Opinion

The Pharmacies market in D-A-CH, consisting of Germany, Austria, and Switzerland, is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to this positive trajectory. Customer preferences in the D-A-CH region are playing a crucial role in the growth of the Pharmacies market. Consumers in these countries value convenience and accessibility when it comes to healthcare services. Pharmacies provide a one-stop solution for their healthcare needs, offering a wide range of over-the-counter medications, prescription drugs, and health products. The convenience of being able to consult with pharmacists and obtain medications in one location is highly appealing to customers in the region. Trends in the market are also driving the growth of the Pharmacies industry in D-A-CH. One notable trend is the increasing focus on holistic health and wellness. Customers are becoming more conscious of their overall well-being and are seeking out pharmacies that offer a diverse range of products and services to support their health goals. Pharmacies in D-A-CH are responding to this trend by expanding their product offerings to include natural and alternative remedies, nutritional supplements, and personal care products. Another trend in the Pharmacies market is the integration of technology and digital services. D-A-CH countries have a high level of digitalization, and pharmacies are leveraging this to enhance customer experience and streamline operations. Online ordering and delivery services are becoming increasingly popular, allowing customers to conveniently purchase medications and health products from the comfort of their homes. Additionally, pharmacies are implementing digital solutions such as electronic prescriptions and online consultations to improve efficiency and accessibility. Local special circumstances in each country within the D-A-CH region also contribute to the development of the Pharmacies market. Germany, for example, has a strong healthcare system with a high level of insurance coverage. This ensures that a large portion of the population has access to affordable healthcare services, including medications. Austria and Switzerland also have well-established healthcare systems, with a focus on quality and accessibility. These factors create a favorable environment for the growth of the Pharmacies industry in the region. Underlying macroeconomic factors further support the positive development of the Pharmacies market in D-A-CH. The region has a stable and prosperous economy, with high levels of disposable income and consumer spending. This allows customers to prioritize their health and invest in healthcare products and services. Additionally, the aging population in D-A-CH countries is driving increased demand for healthcare services, including medications. As the population continues to age, the need for pharmacies and their services will only continue to grow. In conclusion, the Pharmacies market in D-A-CH is experiencing growth and development due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The focus on convenience, holistic health, and digitalization, combined with the strong healthcare systems and favorable economic conditions, are driving the success of the Pharmacies industry in the region.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.